Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.
Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR. Higgins P, et al. Among authors: walters mr. Cardiovasc Ther. 2012 Aug;30(4):217-26. doi: 10.1111/j.1755-5922.2011.00277.x. Epub 2011 Jun 12. Cardiovasc Ther. 2012. PMID: 22099531 Review.
Vasopeptidase inhibition: cardiovascular therapy for the new millennium?
Walters M, Reid J. Walters M, et al. J Hum Hypertens. 2000 Sep;14(9):537-9. doi: 10.1038/sj.jhh.1001101. J Hum Hypertens. 2000. PMID: 10980583 No abstract available.
Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction.
Walters M, Muir S, Shah I, Lees K. Walters M, et al. Stroke. 2004 Aug;35(8):1899-902. doi: 10.1161/01.STR.0000131748.12553.ed. Epub 2004 May 27. Stroke. 2004. PMID: 15166388 Clinical Trial.
Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ. Nazir FS, et al. Among authors: walters mr. Diabet Med. 2006 Apr;23(4):398-402. doi: 10.1111/j.1464-5491.2006.01815.x. Diabet Med. 2006. PMID: 16620268
Comparison of the effect of diuretics on carotid blood flow in stroke patients.
Milia P, Muir S, Alem M, Lees K, Walters M. Milia P, et al. Among authors: walters m. J Cardiovasc Pharmacol. 2006 Mar;47(3):446-9. doi: 10.1097/01.fjc.0000211707.64993.85. J Cardiovasc Pharmacol. 2006. PMID: 16633088 Clinical Trial.
Uric acid reduction: a new paradigm in the management of cardiovascular risk?
Dawson J, Quinn T, Walters M. Dawson J, et al. Among authors: walters m. Curr Med Chem. 2007;14(17):1879-86. doi: 10.2174/092986707781058797. Curr Med Chem. 2007. PMID: 17627523 Review.
Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial.
Muir SW, Harrow C, Dawson J, Lees KR, Weir CJ, Sattar N, Walters MR. Muir SW, et al. Among authors: walters mr. Stroke. 2008 Dec;39(12):3303-7. doi: 10.1161/STROKEAHA.108.519793. Epub 2008 Oct 9. Stroke. 2008. PMID: 18845806 Clinical Trial.
Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
Dawson J, Quinn T, Harrow C, Lees KR, Weir CJ, Cleland SJ, Walters MR. Dawson J, et al. Among authors: walters mr. Diabetes Care. 2009 Jan;32(1):135-7. doi: 10.2337/dc08-1179. Epub 2008 Oct 22. Diabetes Care. 2009. PMID: 18945924 Free PMC article. Clinical Trial.
Functional outcome measures in contemporary stroke trials.
Quinn TJ, Dawson J, Walters MR, Lees KR. Quinn TJ, et al. Among authors: walters mr. Int J Stroke. 2009 Jun;4(3):200-5. doi: 10.1111/j.1747-4949.2009.00271.x. Int J Stroke. 2009. PMID: 19659822 Review.
The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.
Dawson J, Quinn TJ, Harrow C, Lees KR, Walters MR. Dawson J, et al. Among authors: walters mr. Br J Clin Pharmacol. 2009 Nov;68(5):662-8. doi: 10.1111/j.1365-2125.2009.03497.x. Br J Clin Pharmacol. 2009. PMID: 19916990 Free PMC article. Clinical Trial.
153 results
Jump to page
Feedback